-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Amrize, Lowers Price Target to $42

Benzinga·09/22/2026 14:34:09
Listen to the news
UBS analyst Julian Radlinger maintains Amrize (NYSE:AMRZ) with a Neutral and lowers the price target from $57 to $42.